SCHEMBL1103622

SCHEMBL1103622

Cc1ccc2c(-c3ccc4c(c3)C(C)(C)c3ccccc3-4)c3cnccc3c(-c3ccc4c(c3)C(C)(C)c3ccccc3-4)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
ACHE P22303 2/20 0.35
MAP2K4 P45985 1/20 0.32
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
PIK3CD O00329 1/20 0.31
CYP17A1 P05093 1/20 0.31
CASP3 P42574 1/20 0.30
RAB9A P51151 1/20 0.30
ATM Q13315 1/20 0.30
SENP8 Q96LD8 1/20 0.30
SENP7 Q9BQF6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103653 0.94 GSK3B (0.36) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL1103654 0.92 KDR (0.35) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL16298709 0.92 PDK2 (0.39) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL1103644 0.92 PDK2 (0.40) PDK2PIK3CDTDP1TNF
SCHEMBL1103695 0.92 PDK2 (0.40) PDK2PIK3CDTDP1TNF
SCHEMBL16298676 0.91 PDK2 (0.41) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL1102563 0.90 PDK2 (0.40) PDK2PIK3CDTDP1TNF
SCHEMBL1105443 0.90 TDO2 (0.35) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL13487858 0.89 MAPT (0.41) PDK2NPSR1KDM4EMEN1ALDH1A1
SCHEMBL1102578 0.89 PDK2 (0.41) PDK2PIK3CDTDP1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 PDK2 1930/4885NPSR1 4037/4885KDM4E 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.